Buprenorphine - NDC Database
91 records found:
Sorted by NDC Code
0054-0176 Oct 08, 2009
Buprenorphine 2 mg (As Buprenorphine Hydrochloride 2.16 mg) Sublingual Tablet by Roxane Laboratories, Inc
Buprenorphine 2 mg (As Buprenorphine Hydrochloride 2.16 mg) Sublingual Tablet by Roxane Laboratories, Inc
0054-0177 Oct 08, 2009
Buprenorphine 8 mg (As Buprenorphine Hydrochloride 8.64 mg) Sublingual Tablet by Roxane Laboratories, Inc
Buprenorphine 8 mg (As Buprenorphine Hydrochloride 8.64 mg) Sublingual Tablet by Roxane Laboratories, Inc
0093-3600 May 30, 2017
Buprenorphine 5 ug/H Transdermal Patch, Extended Release by Teva Pharmaceuticals USA, Inc.
Buprenorphine 5 ug/H Transdermal Patch, Extended Release by Teva Pharmaceuticals USA, Inc.
0093-3601 May 30, 2017
Buprenorphine 10 ug/H Transdermal Patch, Extended Release by Teva Pharmaceuticals USA, Inc.
Buprenorphine 10 ug/H Transdermal Patch, Extended Release by Teva Pharmaceuticals USA, Inc.
0093-3602 May 30, 2017
Buprenorphine 15 ug/H Transdermal Patch, Extended Release by Teva Pharmaceuticals USA, Inc.
Buprenorphine 15 ug/H Transdermal Patch, Extended Release by Teva Pharmaceuticals USA, Inc.
0093-3603 May 30, 2017
Buprenorphine 20 ug/H Transdermal Patch, Extended Release by Teva Pharmaceuticals USA, Inc.
Buprenorphine 20 ug/H Transdermal Patch, Extended Release by Teva Pharmaceuticals USA, Inc.
0093-3656 Nov 26, 2018
Buprenorphine 5 ug/H Transdermal Patch, Extended Release by Teva Pharmaceuticals USA, Inc.
Buprenorphine 5 ug/H Transdermal Patch, Extended Release by Teva Pharmaceuticals USA, Inc.
0093-3657 Nov 26, 2018
Buprenorphine 10 ug/H Transdermal Patch, Extended Release by Teva Pharmaceuticals USA, Inc.
Buprenorphine 10 ug/H Transdermal Patch, Extended Release by Teva Pharmaceuticals USA, Inc.
0093-3658 Nov 26, 2018
Buprenorphine 15 ug/H Transdermal Patch, Extended Release by Teva Pharmaceuticals USA, Inc.
Buprenorphine 15 ug/H Transdermal Patch, Extended Release by Teva Pharmaceuticals USA, Inc.
0093-3659 Nov 26, 2018
Buprenorphine 20 ug/H Transdermal Patch, Extended Release by Teva Pharmaceuticals USA, Inc.
Buprenorphine 20 ug/H Transdermal Patch, Extended Release by Teva Pharmaceuticals USA, Inc.
0093-5378 May 25, 2010
Buprenorphine 2 mg (As Buprenorphine Hydrochloride 2.16 mg) Sublingual Tablet by Teva Pharmaceuticals USA Inc
Buprenorphine 2 mg (As Buprenorphine Hydrochloride 2.16 mg) Sublingual Tablet by Teva Pharmaceuticals USA Inc
0093-5379 May 25, 2010
Buprenorphine 8 mg (As Buprenorphine Hydrochloride 8.64 mg) Sublingual Tablet by Teva Pharmaceuticals USA Inc
Buprenorphine 8 mg (As Buprenorphine Hydrochloride 8.64 mg) Sublingual Tablet by Teva Pharmaceuticals USA Inc
0143-9246 May 25, 2005
Buprenorphine Hydrochloride .324 mg/ml Intramuscular; Intravenous Injection by Hikma Pharmaceuticals USA Inc.
Buprenorphine Hydrochloride .324 mg/ml Intramuscular; Intravenous Injection by Hikma Pharmaceuticals USA Inc.
0378-0923 Mar 06, 2015
Buprenorphine Hydrochloride Sublingual 2 mg Sublingual Tablet by Mylan Pharmaceuticals Inc.
Buprenorphine Hydrochloride Sublingual 2 mg Sublingual Tablet by Mylan Pharmaceuticals Inc.
0378-0924 Mar 06, 2015
Buprenorphine Hydrochloride Sublingual 8 mg Sublingual Tablet by Mylan Pharmaceuticals Inc.
Buprenorphine Hydrochloride Sublingual 8 mg Sublingual Tablet by Mylan Pharmaceuticals Inc.
0409-2012 Jul 12, 2010
Buprenorphine Hydrochloride .3 mg/ml Intramuscular; Intravenous Injection, Solution by Hospira, Inc.
Buprenorphine Hydrochloride .3 mg/ml Intramuscular; Intravenous Injection, Solution by Hospira, Inc.
0517-0725 Aug 13, 2010
Buprenorphine Hydrochloride .324 mg/ml Intramuscular; Intravenous Injection, Solution by American Regent, Inc.
Buprenorphine Hydrochloride .324 mg/ml Intramuscular; Intravenous Injection, Solution by American Regent, Inc.
21695-515 Jul 12, 2010
Buprenorphine Hydrochloride .3 mg/ml Intramuscular; Intravenous Injection, Solution by Rebel Distributors Corp
Buprenorphine Hydrochloride .3 mg/ml Intramuscular; Intravenous Injection, Solution by Rebel Distributors Corp
5 pages of records were found.
Notice: The MedsChat® NDC Database compiles publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.
